Search
for
Sort by
Research 121–150 of 1000+
- Safety and efficacy of tofacitinib in 97 alopecia areata patients
- Supplementary Material for: Janus Kinase Inhibitors for the Treatment of Severe Alopecia Areata: An Open-Label Comparative Study
- Deuruxolitinib for Alopecia Areata.
- Tofacitinib for the treatment of alopecia areata in preadolescent children
- A Novel Hope for Alopecia Totalis Patients: Case Report
- Use of intramuscular triamcinolone acetonide in intermediate responders to janus kinase inhibition for alopecia areata: Case report
- Real-Life Effectiveness and Tolerance of Baricitinib for the Treatment of Severe Alopecia Areata with 1-Year Follow-Up Data
- ISID1108 - Comparison of ruxolitinib and a collagen-targeted PTH-based hair cycle stimulant on hair follicle counts and hair growth in the C3H/HeJ engrafted mouse model of alopecia areata.
- 1108 Comparison of ruxolitinib and a collagen-targeted PTH-based hair cycle stimulant on hair follicle counts and hair growth in the C3H/HeJ engrafted mouse model of alopecia areata
- SnapshotDx Quiz: September 2018
- The relative efficacy of monotherapy with Janus kinase inhibitors, dupilumab and apremilast in adults with alopecia areata: Network meta‐analyses of clinical trials
- Alopecia areata: from pathophysiology to therapeutic innovation
- Alopecia areata: current concepts
- Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
- Janus Kinase Inhibitors in Dermatology: Part 1 — General Considerations and Applications in Vitiligo and Alopecia Areata
- Recent Insight on the Management of Lupus Erythematosus Alopecia
- Delphi Consensus Statement on Treatment of Severe Alopecia Areata in US Adults
- Abrocitinib Treatment in Diffuse Alopecia Areata: A Case Report and a Literature Review
- New Treatment Strategies in Management of Alopecia Areata: Review Article
- High throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in Alopecia Areata
- Inhibidor janus kinasa como opción terapéutica en alopecia areata. Reporte de caso
- A Case of Vitiligo Combined with Systemic Lupus Erythematosus Treated with Tofacitinib
- 26 Characterization of a murine model of aa induced by adoptive transfer of cultured lymph node cells
- Small Molecule Inhibitors and Inflammatory Skin Diseases
- Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients
- Janus kinase (JAK)
- Hypohidrotic Ectodermal Dysplasia with c.28delG Mutation in Ectodysplasin A Gene and Severe Atopic Dermatitis Treated Successfully with Tofacitinib
- Janus Kinase Inhibitors - A next generation treatment in Dermatology
- Complete Reversal of Alopecia Universalis Using Tofacitinib in a Patient with Rheumatoid Arthritis: A Case Report
- JAK Family Expression and Therapeutic Implications in Primary Cicatricial Alopecias